Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: Anticancer Drugs. 2016 Mar;27(3):216–224. doi: 10.1097/CAD.0000000000000319

Figure 5. VRL/DVRL on angiogenic and anti-angiogenic proteins in the protracted administration model.

Figure 5

A) IL-8 and TSP-1 protein levels were determined by ELISA B)protein levels of COX-2, PPARgamma and CD36 were determined by western blotting using respective antibodies;last blot shows only the non-glycosylated but full-lenth CD36 protein (55kDa). Numbers under the blotts indicate normalized to b-actin values of respective proteins. Representative figures of 2 independent experiments are shown. *p<0.05 compared with control group.